Comparative Effectiveness of Upadacitinib Versus Ustekinumab in Ulcerative Colitis Patients With Prior Tumor Necrosis Factor Inhibitor Exposure: A matched Cohort Study - PubMed
4 hours ago
- #ustekinumab
- #upadacitinib
- #ulcerative colitis
- Study compares upadacitinib and ustekinumab in ulcerative colitis patients with prior anti-TNF exposure.
- Upadacitinib showed lower oral corticosteroid use (40.1%) compared to ustekinumab (48.5%) at 1-year follow-up.
- No significant differences found in colectomy rates, ED visits, or hospitalizations between the two treatments.
- Findings suggest upadacitinib may be more effective than ustekinumab in this patient population.